A flexible 16-channel custom coil array for accelerated imaging of upper and infraglottic airway at 3 T

PURPOSE

To develop a custom coil and evaluate its utility for accelerated upper and infraglottic airway MRI at 3 T.

METHODS

A 16-channel flexible and anatomy-conforming coil was developed to provide localized sensitivity over upper and infraglottic airway regions of interest. Parallel-imaging capabilities were compared against existing head and head-neck coils. SENSE geometry factor losses were quantified for retrospectively accelerating 3D MRI. Blinded image-quality ratings from two experts were performed. Spiral GRAPPA reconstructions were evaluated for a speaking task at a time resolution of 40 ms. Contrast-to-noise ratios between air and tissue at key landmarks along the vocal tract were compared. SENSE imaging with the custom coil in the lateral recumbent posture was evaluated. Multislice imaging was performed to image swallowing at 17 ms/frame via constrained reconstruction.

RESULTS

The custom coil showed improved SENSE imaging up to 3-fold acceleration when accelerated along either the anterior-posterior or the superior-inferior direction and a net 4-fold acceleration when accelerated along both directions. Spiral GRAPPA reconstructions with the custom coil showed higher contrast-to-noise ratio when compared with existing coils. In the lateral posture, robust SENSE imaging was achieved at up to 2-fold and 3-fold acceleration levels in the superior-inferior and anterior-posterior directions, respectively. Key events of swallowing in the multislice dynamic images were identified by an otolaryngologist.

CONCLUSION

The coil provided improved parallel imaging of upper and infraglottic airway in both supine and lateral recumbent postures. It enabled efficient accelerated dynamic imaging of speaking and swallowing.

An international effort towards developing standards for best practices in analysis, interpretation and reporting of clinical genome sequencing results in the CLARITY Challenge

Background

There is tremendous potential for genome sequencing to improve clinical diagnosis and care once it becomes routinely accessible, but this will require formalizing research methods into clinical best practices in the areas of sequence data generation, analysis, interpretation and reporting. The CLARITY Challenge was designed to spur convergence in methods for diagnosing genetic disease starting from clinical case history and genome sequencing data. DNA samples were obtained from three families with heritable genetic disorders and genomic sequence data were donated by sequencing platform vendors. The challenge was to analyze and interpret these data with the goals of identifying disease-causing variants and reporting the findings in a clinically useful format. Participating contestant groups were solicited broadly, and an independent panel of judges evaluated their performance.

Results

A total of 30 international groups were engaged. The entries reveal a general convergence of practices on most elements of the analysis and interpretation process. However, even given this commonality of approach, only two groups identified the consensus candidate variants in all disease cases, demonstrating a need for consistent fine-tuning of the generally accepted methods. There was greater diversity of the final clinical report content and in the patient consenting process, demonstrating that these areas require additional exploration and standardization.

Conclusions

The CLARITY Challenge provides a comprehensive assessment of current practices for using genome sequencing to diagnose and report genetic diseases. There is remarkable convergence in bioinformatic techniques, but medical interpretation and reporting are areas that require further development by many groups.

Otolaryngology head and neck surgery: an integrative view of the larynx

The glottis is composed of muscular, cartilaginous, and other viscoelastic tissues which perform some of our most important, complex, coordinated, and life-sustaining functions. Dominated by the thyroarytenoid muscles and associated glottic closure muscles, the larynx is involved in respiration, swallowing, voicing, coughing, valsalva, vomiting, laughing, and crying. With respiration continuing in the background, all other "secondary" laryngeal events seamlessly occur. When the delicate balance of coordinating these events is disrupted by disease or disorder, many of these tasks are compromised. Due to the complex innervation of these volitional and reflexive tasks with brainstem central pattern generators, primary sensorimotor areas and importantly, limbic areas, failure can occur due to disease, anatomic compromise, and even emotional state. Understanding the level of sensorimotor control and interaction among systems that share these laryngeal neuromuscular substrates will improve the diagnostic and therapeutic skill of the clinician when treating compromise of laryngeal function.

Ultrasound-Guided Needle Localization of Recurrent Paratracheal Thyroid Cancer

Objectives:

Ultrasound-guided needle localization techniques have been used to direct the resection of targeted axillary lymph nodes in the management of breast cancer. To date, there has been only one other description of this technique as a localization method to direct cancer resection in the neck. We offer further support for the broader application of this technique by reporting its use in the successful identification and resection of recurrent papillary thyroid cancer after a paratracheal node dissection failed to localize the cancer.

Methods:

We report a case and discuss the relevant literature regarding ultrasound-guided localization and resection of recurrent well-differentiated thyroid cancer.

Results:

We were able to achieve successful identification and resection of recurrent papillary thyroid cancer using this technique.

Conclusions:

This technique may be useful in the treatment of selected cases of recurrent thyroid cancer to increase the efficacy and safety of surgical resection.

Retrograde labeling of the rat facial nerve with carbocyanine dyes to enhance intraoperative identification

OBJECTIVES

Removal of head and neck neoplasms, especially those of the parotid gland and those of the internal auditory canal and cerebellopontine angle, often requires microdissection of the facial nerve. Displacement or splaying of the nerve can make it difficult to identify facial nerve fibers and/or distinguish them from surrounding tissues. Here we tested a method of labeling the facial nerve with fluorescent lipophilic dyes as a method of providing intraoperative visual confirmation of nerve fibers.

METHODS

The facial nerves of adult rats were retrogradely labeled with 1,1'-dioctadecyl-3,3,3',3'-tetramethylindocarbocyanine perchlorate (DiI), 3,3'-dioctadecyloxacarbocyanine perchlorate (DiO), or 3,3'-dilinoleyloxacarbocyanine perchlorate (Fast DiO) either by direct application to the nerve sheath or by microinjection into the facial muscles. The nerves were examined 30 days after dye application by means of a dissecting stereomicroscope equipped with epifluorescence filters.

RESULTS

Of the dyes tested, Fast DiO proved to be the most effective, providing labeling of the nerve sufficient to be seen with combined fluorescent and bright field stereomicroscopy. Nerve conduction studies indicated that fluorescent labeling did not adversely affect nerve function.

CONCLUSIONS

These results raise the possibility of using fluorescent lipophilic dyes to label nerves as a method of enhancing identification and distinguishing nerve fibers during surgery.